TR199900943T2 - Pyrimidine t�revlerinin haz�rlanma procession. - Google Patents

Pyrimidine t�revlerinin haz�rlanma procession.

Info

Publication number
TR199900943T2
TR199900943T2 TR1999/00943T TR9900943T TR199900943T2 TR 199900943 T2 TR199900943 T2 TR 199900943T2 TR 1999/00943 T TR1999/00943 T TR 1999/00943T TR 9900943 T TR9900943 T TR 9900943T TR 199900943 T2 TR199900943 T2 TR 199900943T2
Authority
TR
Turkey
Prior art keywords
rlanma
revlerinin
haz
procession
pyrimidine
Prior art date
Application number
TR1999/00943T
Other languages
Turkish (tr)
Inventor
Wha Hong You
Nam Lee Young
Bae Kim Hong
Original Assignee
Yuhan Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from KR1019960049381A external-priority patent/KR100193080B1/en
Priority claimed from KR1019960049382A external-priority patent/KR100209587B1/en
Priority claimed from KR1019960049380A external-priority patent/KR0185292B1/en
Application filed by Yuhan Corporation filed Critical Yuhan Corporation
Publication of TR199900943T2 publication Critical patent/TR199900943T2/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32One oxygen, sulfur or nitrogen atom
    • C07D239/42One nitrogen atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/02Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

Bu bulus, öncelikle, formül (I) ile ifade edilenThis invention is primarily expressed in formula (I).

TR1999/00943T 1996-10-29 1997-10-27 Pyrimidine t�revlerinin haz�rlanma procession. TR199900943T2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR1019960049381A KR100193080B1 (en) 1996-10-29 1996-10-29 Method for preparing (R) -pyrimidine derivative
KR1019960049382A KR100209587B1 (en) 1996-10-29 1996-10-29 Process of the preparing pyrimidine derivatives
KR1019960049380A KR0185292B1 (en) 1996-10-29 1996-10-29 Process for preparation of (s)-pyrimidine derivatives

Publications (1)

Publication Number Publication Date
TR199900943T2 true TR199900943T2 (en) 1999-12-21

Family

ID=27349413

Family Applications (1)

Application Number Title Priority Date Filing Date
TR1999/00943T TR199900943T2 (en) 1996-10-29 1997-10-27 Pyrimidine t�revlerinin haz�rlanma procession.

Country Status (5)

Country Link
AR (1) AR009133A1 (en)
BR (1) BR9712392A (en)
HU (1) HU226752B1 (en)
TR (1) TR199900943T2 (en)
WO (1) WO1998018784A1 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100272471B1 (en) * 1998-11-17 2000-11-15 김선진 Novel pyrimidine derivatives and processes for the preparation thereof
US6852739B1 (en) 1999-02-26 2005-02-08 Nitromed Inc. Methods using proton pump inhibitors and nitric oxide donors
GB0110338D0 (en) * 2001-04-27 2001-06-20 Sb Pharmco Inc Novel processes
US7211590B2 (en) 2002-08-01 2007-05-01 Nitromed, Inc. Nitrosated proton pump inhibitors, compositions and methods of use
US7776873B2 (en) 2005-12-01 2010-08-17 Yuhan Corporation Method for treating damage to gastric mucosa
KR101784001B1 (en) 2006-04-04 2017-10-23 케이지 액퀴지션 엘엘씨 Oral dosage forms including an antiplatelet agent and an acid inhibitor
CN102993173B (en) * 2012-12-28 2014-09-03 山东大学 Preparation method of revaprzan hydrochloride
CN105601611A (en) 2014-11-19 2016-05-25 江苏天士力帝益药业有限公司 Revaprzan hydrochloride polymorphic substance and preparation method thereof
CN105669642B (en) 2014-11-19 2020-06-09 江苏天士力帝益药业有限公司 Preparation method of loflupridine hydrochloride
CN107759562B (en) * 2016-08-21 2020-10-23 常州四药制药有限公司 Preparation method of loflupridine hydrochloride

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1182584A (en) * 1966-03-31 1970-02-25 Ici Ltd Pyrimidine derivates and the use thereof as fungicides
ES2081863T3 (en) * 1989-03-22 1996-03-16 Ciba Geigy Ag PESTICIDES.
KR0144833B1 (en) * 1992-12-28 1998-07-15 김태훈 Novel quinazoline derivatives and their preparation
AU688087B2 (en) * 1994-08-13 1998-03-05 Yuhan Corporation Novel pyrimidine derivatives and processes for the preparation thereof

Also Published As

Publication number Publication date
HUP9903520A1 (en) 2000-05-28
AR009133A1 (en) 2000-03-08
HUP9903520A3 (en) 2002-01-28
HU226752B1 (en) 2009-09-28
WO1998018784A1 (en) 1998-05-07
BR9712392A (en) 2000-01-25

Similar Documents

Publication Publication Date Title
ES2110386T1 (en) INTERFERON CONJUGATES.
TR199900885T2 (en) Methods and compounds containing therapeutic isoflavones.
ID23374A (en) HALOGENOPIRIMIDIN
TR199701146T1 (en) 1-Phenylpyrazole-3-Carboxamides acting on neurotensin receptors.
TR200101764T2 (en) New compounds.
TR199802240T2 (en)
PT1140944E (en) EPOTILONE DERIVATIVES AND THEIR USE AS ANTITUMATIC AGENTS
ATE246678T1 (en) CYCLIC AMIDINO AGENTS AS NITROGEN OXIDE SYNTHASE INHIBITORS
GR3024181T3 (en) N-(alkanoylamino-2-hydroxypropyl)-sulfonamides useful as retroviral protease inhibitors.
BR9808491A (en) Calcilic compounds
PT998460E (en) NEW TETRAZOLE DERIVATIVES
DE69835215D1 (en) INHIBITORS OF PHOSPHOSERIN AND PHOSPHOTHREONINPECIFIC ISOMERASES
ATE196628T1 (en) HYDROXYAMIDINE DERIVATIVES USABLE AS NITROGEN OXIDE SYNTHESIS INHIBITORS
TR199900943T2 (en) Pyrimidine t�revlerinin haz�rlanma procession.
ATE227282T1 (en) 2,4-DIAMINOPYRIMIDINE DERIVATIVES
BG102395A (en) New phenylamidine derivatives, method for their preparation and application as medicamentous forms
DE68915112D1 (en) Spiro-isoquinoline-pyrrolidine tetrones and analogues thereof, useful as aldose reductase inhibitors.
GB2324091B (en) Metalloproteinase inhibitors
TR199701298T1 (en) Tetralins.
EA200000875A1 (en) PROTEINS INTERACTING WITH CASPASE-8
NO990849D0 (en) Substituted 1,2,3,4-tetrahydro-2-dibenzofuranamines and 2-aminocyclohepta (b) benzofurans
TR199700761A2 (en) Ksanten ve akridin tärrleri ve bunlar�n kullan�m�.
DE69813753D1 (en) BELT DIFFERENTIAL.
UY24915A1 (en) DERIVATIVES OF BENZOXAZINDIONA, APPLICATION OF THE SAME AND MEDICINES THAT CONTAIN THEM
TR200003203T2 (en) Purification of carboxaldehyde